- Cefprozil
-
Cefprozil Systematic (IUPAC) name 7-[2-amino-2-(4-hydroxyphenyl)-acetyl]amino-8-oxo-3-prop-1-enyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Clinical data Trade names Cefzil AHFS/Drugs.com monograph MedlinePlus a698022 Licence data US FDA:link Pregnancy cat. B(US) Legal status ℞-only (US) Routes Oral Pharmacokinetic data Bioavailability 95% Protein binding 36% Half-life 1.3 hours Identifiers CAS number 92665-29-7 ATC code J01DC10 PubChem CID 9887643 DrugBank APRD00461 ChemSpider 8063315 UNII 1M698F4H4E KEGG D07651 ChEMBL CHEMBL1742 Chemical data Formula C18H19N3O5S Mol. mass 389.427 g/mol SMILES eMolecules & PubChem (what is this?) (verify) Cefprozil, sometimes spelled cefproxil and marketed under the trade name Cefzil, is a second-generation cephalosporin type antibiotic. In Europe it is marketed using the trade names Procef and Cronocef.[citation needed] It can be used to treat bronchitis, ear infections, skin infections, and other bacterial infections.[citation needed] It comes as a tablet and as a liquid suspension.
Although there is a widely quoted cross-allergy risk of 10% between cephalosporins and penicillin, an article in the Journal of Family Practice[1] has shown no increased risk for cross-allergy for cefprozil and several other second-generation or later cephalosporins.
References
- ^ Pichichero, ME (February 2006). "Cephalosporins can be prescribed safely for penicillin-allergic patients". J Fam Pract 55 (2): 106–12. PMID 16451776. http://www.jfponline.com/pdf%2F5502%2F5502JFP%5FAppliedEvidence1%2Epdf.
External links
- Cefprozil MedlinePlus Drug Information
This systemic antibacterial-related article is a stub. You can help Wikipedia by expanding it.